Introduction and Objective: GCGR agonism stimulates energy expenditure (EE) and weight loss in rodents. Moreover, when combined with the antidiabetic actions of incretins (GLP1, GIP), GCGR-agonists lack hyperglycemic side effects. We also identified anti-obesity effects of GCGR agonism for 50d after treatment cessation. Thus, we hypothesized that a GLP-1/GIP/GCGR triple agonist (GGG) will increase EE […]
Read MoreAuthor: sugaradmin
688-P: Personality as a Predictor of Self-Management, Diabetes Distress, and Glycemic Control in Adults with Type 1 Diabetes (T1D)
Introduction and Objective: Personality may influence key glycemic, behavioral, and emotional outcomes in people with T1D. We investigated Five-Factor Model (FFM) personality traits as predictors of self-management (SM), diabetes distress, and continuous glucose monitoring (CGM) metrics among 187 diverse adults with T1D.Methods: Participants wore CGM and rated their SM (each evening on a 0-100 scale) […]
Read More1606-P: Impact of Insulin Resistance and BMI on Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in Nondiabetic Individuals
Introduction and Objective: Insulin resistance (IR) and higher BMI are associated with the development of MASLD. However, their independent association with “at-risk” MASLD (i.e., steatohepatitis with clinically significant fibrosis or stage ≥F2; MASLD≥F2) is unclear. We investigated how IR and obesity interact to impact MASLD severity.Methods: We divided 283 individuals without diabetes into having overweight […]
Read More261-OR: Validation of Mitraa, a GPT-Based Conversational Model for Enhancing Diabetes Self-Management and Education
Introduction and Objective: The growing prevalence of diabetes underscores the need for scalable, patient-centric tools to support diabetes self-management and education (DSME). Mitraa, a GPT-based conversational AI model, was developed to provide personalized diabetes care, including guidance on nutrition, medication adherence, glucose monitoring, and lifestyle adjustments. This study validates Mitraa’s effectiveness in delivering accurate, patient-relevant […]
Read More1605-P: Insulin Resistance Promotes Steatosis and Increases the Risk of Clinically Significant Fibrosis in People with Type 2 Diabetes
Introduction and Objective: Type 2 diabetes (T2D) is often associated with metabolic dysfunction-associated steatotic liver disease (MASLD) which may lead to clinically significant fibrosis (defined as moderate-to-severe fibrosis stage ≥F2 or “at-risk” MASLD≥F2) and eventually cirrhosis. The role of insulin resistance (IR) in the development of MASLD≥F2 remains unclear. We examined the relationship of IR […]
Read More35-PUB: A Novel Integrated Risk Stratification Framework for Diabetes Management in Saudi MEDGULF-Insured Patients
Introduction and Objective: Chronic diseases like diabetes strain healthcare systems among Saudi MEDGULF insured population. Traditional clinical guidelines and advanced AI-driven methods often exist in silos, hindering comprehensive management. This study introduces an Integrated Clinical-AI Stratification Framework that unifies evidence-based clinical protocols with AI models to enhance early detection, individualized risk stratification, and personalized interventions […]
Read More1604-P: The Severity of Metabolic Dysfunction–Associated Steatohepatitis (MASH) Is Associated with Worse Hepatic Steatosis and Insulin Resistance
Introduction and Objective: Metabolic dysfunction-associated steatotic liver disease (MASLD) is associated with “at-risk” MASH (steatohepatitis with significant fibrosis stage ≥F2) and cirrhosis. Magnetic resonance (MR) iron-corrected T1 mapping (cT1) allows for improved MASH risk stratification, but whether it may help define their metabolic profile needs further validation.Methods: We measured AST, ALT, HbA1c, insulin, FFA, liver […]
Read More358-OR: Acute Fatty Acid Elevation Does Not Alter Brain Glucose Uptake in Humans
Introduction and Objective: Acute elevation of non-esterified fatty acids (NEFA) can induce peripheral insulin resistance and impair glucose uptake in muscle. Rodent studies have shown that elevation of NEFA through a high-fat diet impairs brain glucose uptake, and prior observational studies by our group have reported that higher NEFA levels correlate with lower brain glucose. […]
Read More1603-P: ROCK1 in Hepatic Stellate Cells Regulates Insulin Sensitivity and Communicates with Muscle during Overnutrition
Introduction and Objective: Hepatic stellate cells (HSCs) play a key role in developing insulin resistance. While Rho-kinase 1 (ROCK1) activation in hepatocytes promotes obesity-induced insulin resistance, the physiological role of ROCK1 in HSCs remains unclear. This study investigated the importance of ROCK1 in HSCs in the context of obesity-related metabolic dysfunction.Methods: Mice lacking ROCK1 in […]
Read More1844-P: Cytokines Function to Mediate an Innate Immune/Endocrine Axis
Introduction and Objective: It has been suggested that infection may contribute to T1D development via extended exposure of islets to proinflammatory cytokines. Recent evidence, however, suggests that the primary effects of cytokine signaling in islets may be protective through the upregulation of antipathogen and antioxidant genes in β-cells. This study tests the hypothesis that there […]
Read More